SBS Code
stringlengths 9
11
| SBS Code (Hyphenated)
stringlengths 11
12
| Short Description
stringlengths 3
74
| Long Description
stringlengths 7
544
| Chapter
float64 1
25
⌀ | Chapter Name
stringclasses 25
values | Block
int64 1
4.02k
| Block Name
stringlengths 3
99
⌀ | Definition
stringlengths 11
1.18k
⌀ | Includes
stringlengths 4
1.31k
⌀ | Excludes
stringlengths 1
1.23k
⌀ | Guidelines
stringlengths 1
1.54k
⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|
733500150 | 73350-01-50 | FANCC gene; variants | Fanconi anemia, complementation group C (FANCC) common gene variants analysis (e.g. IVS4+4A>T) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Fanconi anemia, type C). | null | null | null |
733500160 | 73350-01-60 | FLT3 gene; ITD | Fms-related tyrosine kinase 3 (FTL3) gene analysis of internal tandem duplication variants (TTD) (e.g. exons 14, 15) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. acute myeloid leukemia). | null | null | null |
733500810 | 73350-08-10 | MSH6 gene; Familial variant | MutS homolog 6 [E. coli] (MSH6) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. Lynch syndrome) | null | null | null |
733500811 | 73350-08-11 | MSH6 gene; Dup/Del | MutS homolog 6 [E. coli] (MSH6) duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for analysis of repeated or deleted nucleotides (e.g. negative tested patients of suspected MSH6 mutations) | null | null | null |
733500200 | 73350-02-00 | G6PC gene; variants | Glucose-6-phosphatase, catalytic subunit (G6PC) common gene variants analysis (e.g. R83C, Q347X) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Glycogen storage disease, type 1a, von Gierke disease) | null | null | null |
733500210 | 73350-02-10 | HFE gene; variants | Hemochromatosis (HFE) common gene variants analysis (e.g. C282Y, H63D) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. hereditary hemochromatosis) | null | null | null |
733500230 | 73350-02-30 | MTHFR gene; variants | Methylenetetrahydrofolate reductase (MTHFR) common gene variants analysis (e.g. 677T, 1298C) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Homocystinuria due to MTHFR deficiency) | null | null | null |
733500231 | 73350-02-31 | MYD88 gene; variants | Myeloid differentiation primary response 88 gene (MYD88) specific gene variant analysis (L265P) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Waldenstrom macroglobulinemia) | null | null | null |
733500232 | 73350-02-32 | NPM1 gene; variants | Nucleophosmin (NPM1) specific gene variant analysis (exon 12 mutations) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. acute myeloid leukemia) | Nucleophosmin (NPM1) specifc gene variant analysis (eon 12 mutations) | null | null |
733500233 | 73350-02-33 | NRAS gene; variants | Neuroblastoma RAS viral, v–ras, oncogene homolog (NRAS) specific gene variant analysis (exon 12; e.g. codons 12, 13) (exon 13; e.g. codon 61) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Waldenstrom macroglobulinemia) | null | null | null |
733500234 | 73350-02-34 | NTRK1 gene; variants | Neurotrophic receptor tyrosine kinase 1 (NTRK1) variant translocation analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection using formalin–fixed paraffin embedded tissue (FFPE) specimen by PCR or NGS (e.g. solid tumors) | null | null | Do not assign this code if the test was performed by methods other than PCR or NGS (e.g. FISH or IHC) instead use specific procedure code as (73200-09-60, 73200-08-30) |
733500235 | 73350-02-35 | NTRK2 gene; variants | Neurotrophic receptor tyrosine kinase 2 (NTRK2) variant translocation analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection using formalin–fixed paraffin embedded tissue (FFPE) specimen by PCR or NGS (e.g. solid tumors) | null | null | Do not assign this code if the test was performed by methods other than PCR or NGS (e.g. FISH or IHC) instead use specific procedure code as (73200-09-60, 73200-08-30) |
733500170 | 73350-01-70 | G6PD gene; variants | Gglucose-6-phosphate dehydrogenase (G6PD) common gene variants analysis (e.g. A, A-) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. hemolytic anemia, jaundice) | null | null | null |
733500180 | 73350-01-80 | G6PD gene; Familial variants | Gglucose-6-phosphate dehydrogenase (G6PD) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. hemolytic anemia, jaundice) | null | null | null |
733500190 | 73350-01-90 | G6PD gene; Full Sequence | Gglucose-6-phosphate dehydrogenase (G6PD) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. hemolytic anemia, jaundice) | null | null | null |
733500236 | 73350-02-36 | NTRK3 gene; variants | Neurotrophic receptor tyrosine kinase 3 (NTRK3) variant translocation analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection using formalin–fixed paraffin embedded tissue (FFPE) specimen by PCR or NGS (e.g. solid tumors) | null | null | Do not assign this code if the test was performed by methods other than PCR or NGS (e.g. FISH or IHC) instead use () |
733500237 | 73350-02-37 | NTRK1/2/3 gene; variants | Neurotrophic receptor tyrosine kinase 1/2/3 (NTRK1/2/3) variant translocation analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection using formalin–fixed paraffin embedded tissue (FFPE) specimen by PCR or NGS (e.g. solid tumors) | null | null | null |
733500238 | 73350-02-38 | NUDT15 gene; variants | Nudix hydrolase 15 gene (NUDT15) common gene variants analysis (e.g. *2, *3, *4, *5, *6) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. before treatment with thiopurines) | null | null | null |
733500239 | 73350-02-39 | PABPN1 gene; Evaluation | Poly[A] binding protein nuclear 1 gene (PABPN1) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for abnormal expanded alleles (e.g. oculopharyngeal muscular dystrophy (OPMD)) | null | null | null |
733500258 | 73350-02-58 | PALB2 gene; Full Sequence | Partner and localizer of BRCA2 (PALB2) full gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. Fanconi anemia, of breast or pancreatic cancer) | Gene panel test and PALB2 gene | null | Do not assign this code If a gene panel test is performed and includes the PALB2 gene (e.g. hereditary breast cancer panel) |
733500259 | 73350-02-59 | PALB2 gene; Familial variant | Partner and localizer of BRCA2 (PALB2) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. Fanconi anemia, of breast or pancreatic cancer) | Gene panel test and PALB2 gene | null | Do not assign this code If a gene panel test is performed and includes the PALB2 gene (e.g. hereditary breast cancer panel) |
733500251 | 73350-02-51 | PIK3CA gene; Target sequence | Phosphatidylinositol–4, 5–biphosphate 3–kinase, catalytic subunit alpha (PIK3CA) specific sequence analysis on exons 7, 9, and 2 | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection on specific site (e.g. breast cancer or colorectal cancer) | null | null | null |
733500252 | 73350-02-52 | PLCG2 gene; variants | Phospholipase C gamma 2 (PLCG2) common gene variants analysis (e.g. R665W, S707F, L845F) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. lymphocytic leukemia (CLL)) | null | null | This test is usually ordered in conjunction to (BTK Gene; Variants) |
733500253 | 73350-02-53 | PML/RARalpha Fusion genes; Common breakpoint; Quant./Qual. | Quantitative/Qualitative translocation analysis (t(15;17)) of common breakpoint regions (e.g. introns 3 AND 6) on the promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) fusion gene | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for breakpoints due to translocation, forming altered gene sequence (e.g. acute promyelocytic leukemia) | null | null | null |
733500254 | 73350-02-54 | PML/RARalpha Fusion genes; Single breakpoint; Quant./Qual. | Quantitative/Qualitative translocation analysis (t(15;17)) of common breakpoint regions (e.g. introns 3 OR 6) on the promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) fusion gene | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for breakpoints due to translocation, forming altered gene sequence (e.g. acute promyelocytic leukemia) | null | null | null |
733500255 | 73350-02-55 | PMP22 gene; Dup/Del | Peripheral myelin protein 22 (PMP22) duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for analysis of repeated or deleted nucleotides (e.g. Charcot–Marie–tooth) | null | null | null |
733500256 | 73350-02-56 | PMP22 gene; Full sequence | Peripheral myelin protein 22 (PMP22) full gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. Charcot–Marie–tooth) | null | null | null |
733500257 | 73350-02-57 | PMP22 gene; Familial variant | Peripheral myelin protein 22 (PMP22) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation)(e.g. Charcot–Marie–tooth) | null | null | null |
733500261 | 73350-02-61 | PMS2 gene; Full Sequence | Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) full gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. Lynch syndrome) | null | null | null |
733500262 | 73350-02-62 | PMS2 gene; Familial variant | Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation)(e.g. Lynch syndrome) | null | null | null |
733500263 | 73350-02-63 | PMS2 gene; Dup/Del | Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for analysis of repeated or deleted nucleotides (e.g. Lynch syndrome) | null | null | null |
733500264 | 73350-02-64 | PPP2R2B gene; Evaluation | Phosphatase 2 regulatory subunit B beta (PPP2R2B) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for abnormal expanded alleles (e.g. spinocerebellar ataxia 12 (SCA12)) | null | null | null |
733500265 | 73350-02-65 | PTEN gene; Full sequence | Phosphatase and tensin homolog (PTEN) full gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. hamartoma tumor syndrome, Cowden syndrome) | null | null | null |
733500266 | 73350-02-66 | PTEN gene; Familial variant | Phosphatase and tensin homolog (PTEN) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. hamartoma tumor syndrome, Cowden syndrome) | null | null | null |
733500267 | 73350-02-67 | PTEN gene; Dup/Del | Phosphatase and tensin homolog (PTEN) duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for analysis of repeated or deleted nucleotides (e.g. hamartoma tumor syndrome, Cowden syndrome) | null | null | null |
733500268 | 73350-02-68 | RUNX1 gene; Target sequence | Runt related transcription factor 1 (RUNX) specific sequence analysis on exons 3–8 | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection on specific site (e.g. acute myeloid leukemia (AML)) | null | null | null |
733500269 | 73350-02-69 | SEPT9 gene; Methylation | Septin9 (SEPT9) promoter methylation analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Test to assess genetic changes related to the disease (e.g. colorectal cancer) | null | null | null |
733500271 | 73350-02-71 | SERPINA1 gene; variants | Serpin peptidase inhibitor, clade A, alpha–1 antiproteinase, antitrypsin, member 1 (SERPINA1) common gene variants analysis (e.g. *S and *Z) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Alpha–1–antitrypsin deficiency) | null | null | null |
733500272 | 73350-02-72 | SF3B1 gene; variants | Splicing factor [3b] subunit B1 (SF3B1) common gene variants analysis (e.g. A672T, E622D, L833F, R625C, R625L) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. myelodysplastic syndrome (MDS) | null | null | null |
733500273 | 73350-02-73 | SLCO1B1 gene; variants | Solute carrier organic anion transporter family, member 1B1 (SLCO1B1) common gene variants analysis (e.g. *5) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. myopathy, assessment of statin therapy risk) | null | null | null |
733500274 | 73350-02-74 | SMN1/SMN2 gene; Deletions | Survival of telomeric motor neuron 1 (SMN1) and survival of centromeric motor neuron 2 (SMN2) deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for analysis of deleted nucleotides (e.g. spinal muscular atrophy (SMA)) | null | null | null |
733500275 | 73350-02-75 | SMN1 gene; Full sequence | Survival of telomeric motor neuron 1 (SMN1) full gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. spinal muscular atrophy (SMA)) | null | null | null |
733500276 | 73350-02-76 | SMN1 gene; Familial variant | Survival of telomeric motor neuron 1 (SMN1) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. spinal muscular atrophy (SMA)) | null | null | null |
733500220 | 73350-02-20 | JAK2 gene; variants | Janus Kinase 2 (JAK2) specific gene variant analysis (V617F) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Erythrocytosis, Leukemia, Thrombocythemia 3) | null | null | null |
733500277 | 73350-02-77 | SMPD1 gene; variants | Sphingomyelin phosphodiesterase 1, acid lysosomal (SMPD1) common gene variants analysis (e.g. R496L, L302P, fsP330) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. Niemann–Pick disease) | null | null | null |
733500278 | 73350-02-78 | SNRPN/UBE3A; Methylation | Small nuclear ribonucleoprotein polypeptide N (SNRPN) and ubiquitin–protein ligase E3A (UBE3A) methylation analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Test to assess genetic changes related to the disease (e.g. Prader–Willi syndrome (PWS) or Angelman syndrome (AS)) | null | null | Do not assign this code if only one of the two genes are tested or if a method other than methylation analysis is utilized. |
733500279 | 73350-02-79 | SRSF2 gene; variants | Serine and arginine–rich splicing factor 2 (SRSF2) common gene variants analysis (e.g. P95H, P95L) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. myeloid disorders) | null | null | null |
733500281 | 73350-02-81 | TBP gene; Evaluation | TATA box binding protein (TBP) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for abnormal expanded alleles (e.g. spinocerebellar ataxia 17 (SCA17)) | null | null | null |
733500282 | 73350-02-82 | TERT gene; Target sequence | Telomerase reverse transcriptase gene (TERT) specific sequence analysis on promotor region | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection on specific site (e.g. central nervous system tumors) | null | null | null |
733500283 | 73350-02-83 | TGFBI gene; variants | Transforming growth factor beta–induced gene (TGFBI) common gene variants analysis (e.g. R124H, R124C, R124L, R555W, R555Q) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. corneal dystrophy) | null | null | null |
733500284 | 73350-02-84 | TP53 gene; Full sequence | Tumor protein 53 (TP53) full gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequence of a gene (e.g. Li–Fraumeni syndrome) | null | TP53 gene testing | Do not assign this code if a panel that includes testing the TP53 gene was performed (e.g. Hereditary breast or colon cancer panels) |
733500285 | 73350-02-85 | TP53 gene; Target Sequence | Tumor protein 53 (TP53) specific sequence analysis (e.g. 4 oncology) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection on specific site (e.g. Li–Fraumeni syndrome) | null | TP53 gene testing | Do not assign this code if a panel that includes testing the TP53 gene was performed (e.g. Hereditary breast or colon cancer panels) |
733500286 | 73350-02-86 | TP53 gene; Familial variant | Tumor protein 53 (TP53) analysis of known familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. Li–Fraumeni syndrome) | null | TP53 gene testing | Do not assign this code if a panel that includes testing the TP53 gene was performed (e.g. Hereditary breast or colon cancer panels) |
733500287 | 73350-02-87 | TPMT gene; variants | Thiopurine S–methyltransferase (TPMT) common gene variants analysis (e.g. *2, *3) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. transplant recipient, acute lymphoblastic leukemia) | null | null | null |
733500291 | 73350-02-91 | TRB@ gene variants; PCR | T–cell populations from T–cell antigen receptor, beta (TCRB; TRB@) gene rearrangements analysis by polymerase chain reaction | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. leukemias, lymphomas) | null | null | null |
733500292 | 73350-02-92 | TRB@ gene variants; Southern blot | T–cell populations from T–cell antigen receptor, beta (TCRB; TRB@) gene rearrangements analysis by Southern blot | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. leukemias, lymphomas) | null | null | null |
733500293 | 73350-02-93 | TRB@ gene variants | T–cell populations from T–cell antigen receptor, beta (TCRB; TRB@) gene rearrangements analysis (abnormal clonal populations) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. leukemias, lymphomas) | null | null | null |
733500294 | 73350-02-94 | TYMS gene; variants | Thymidylate synthetase (TYMS) common gene variants analysis (e.g. tandem repeats) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. solid tumors) | null | null | null |
733500295 | 73350-02-95 | U2AF1 gene; variants | U2 small nuclear RNA auxiliary factor 1 (U2AF1) common gene variants analysis (e.g. S34F, S34Y, Q157R, Q157P) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. hematologic disorders) | null | null | null |
733500296 | 73350-02-96 | UGT1A1 gene; variants | UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1) common gene variants analysis (e.g. *28, *36, *37) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. cancer drug administration, Gilbert syndrome) | null | null | null |
733500288 | 73350-02-88 | VKORC1 gene; variants | Vitamin K epoxide reductase complex, subunit 1(VKORC1) common gene variants analysis (e.g. -1639G>A, c.173+1000C>T) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. blood thinner administration, mechanical heart valve replacement) | null | null | null |
733500289 | 73350-02-89 | ZRSR2 gene; variants | Zinc finger CCCH–type, RNA binding motif and serine/arginine–rich 2 (ZRSR2) common gene variants analysis (e.g. E65fs, E122fs, R448fs) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. hematologic disorders) | null | null | null |
733500521 | 73350-05-21 | Aortic Dysfunction/Dilation Panel | Aortic Dysfunction/Dilation; genomic sequencing analysis panel of minimum 9 genes, containing (FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes involving methods as Next Generation Sequencing (Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, and arterial tortuosity syndrome) | null | null | null |
733500522 | 73350-05-22 | Aortic Dysfunction/Dilation; Dup/Del Panel | Aortic Dysfunction/Dilation; duplication and deletion analysis panel of minimum 9 genes, containing (FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes involving methods as Next Generation Sequencing (Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, and arterial tortuosity syndrome) | null | null | null |
733500523 | 73350-05-23 | Ashkenazi Jewish Disorders Panel | Ashkenazi Jewish associated disorders (e.g. Bloom syndrome, cystic fibrosis, Fanconi C anemia, Tay-Sachs disease); genomic sequence analysis panel of minimum 9 genes, containing (ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, and SMPD1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes involving methods as Next Generation Sequencing (Bloom syndrome, Canavan disease, cystic fibrosis, familial dysautonomia, Fanconi anemia group C, Gaucher disease, Tay-Sachs disease) | Gene sequencing | null | Do not assign code for gene sequencing or any other testing method for genes included in this panel |
733500524 | 73350-05-24 | Cardiac ion channelopathies panel | Cardiac ion channelopathies (e.g. Brugada syndrome, long/short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel of minimum 10 genes, containing (ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes involving methods as Next Generation Sequencing | Gene sequencing | null | Do not assign code for gene sequencing or any other testing method for genes included in this panel |
733500525 | 73350-05-25 | Cardiac Ion Channelopathies; Dup/Del Panel | Cardiac ion channelopathies (e.g. Brugada syndrome, long/short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication and deletion analysis panel of minimum 2 genes, containing (KCNH2 and KCNQ1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes involving methods as Next Generation Sequencing | null | null | null |
733500526 | 73350-05-26 | Epilepsy panel | Epilepsy; genomic sequence analysis panel of minimum 24 genes, containing (ALDH7A1, CACNA1A, CDKL5, CHD2, GABRG2, GRIN2A, KCNQ2, MECP2, PCDH19, POLG, PRRT2, SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC9A6, STXBP1, SYNGAP1, TCF4, TPP1, TSC1, TSC2, and ZEB2) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes involving methods as Next Generation Sequencing | null | null | Do not separately assign individual gene codes in addition to this panel. |
733500527 | 73350-05-27 | Exome analysis | Exome (e.g unexplained disorder); gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Exome analysis for detection of variants potentially causing unexplained disorder | null | null | Do not assign this code with (WGS by NGS). It is possible to report all or any of the following codes together based on the performed testing (Exome Analysis, Exome Analysis; Comparator Reference, Exome Re-Evaluation) |
733500528 | 73350-05-28 | Exome Analysis; Comparator Reference | Exome (e.g unexplained disorder); creation of reference exome gene sequence | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Reference exome creation (from parent, sibling, relative) for comparison to patient in order to evaluate unexplained disorders | null | null | Do not assign this code with (WGS by NGS). This is an additional code to be assigned with (Exome Analysis). Do not report this code alone. It is possible to report all or any of the following codes together based on the performed testing (Exome Analysis, Exome Analysis, Comparator Reference, Exome Re-Evaluation) |
733500529 | 73350-05-29 | Exome re-evaluation | Re-evaluation of existing exome gene sequence (previously obtained) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Reevaluation of patient exome due to emergence of new information | null | null | Do not assign this code for incidental findings. It is possible to report all or any of the following codes together based on the performed testing (Exome Analysis, Exome Analysis, Comparator Reference, Exome Re-Evaluation) |
733500545 | 73350-05-45 | Severe inherited conditions panel | Severe inherited conditions (e.g. cystic fibrosis, Ashkenazi Jewish-associated disorders like [Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], phenylketonuria, beta hemoglobinopathies, galactosemia; gene sequence analysis panel of minimum 15 genes, including (ACADM, ARSA, ASPA, ATP7B). BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | Ashkenazi Jewish Disorders Panel | null | Do not assign this code with (Ashkenazi Jewish Disorders Panel). Do not separately report the genes included in this panel. |
733500546 | 73350-05-46 | X-linked intellectual disability panel | X-linked Intellectual Disability (e.g. syndromic and non-syndromic XLID) genome sequence analysis panel of minimum 60 genes, including (ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | null |
733500547 | 73350-05-47 | X-linked intellectual disability; Dup/Del Panel | X-linked Intellectual Disability (e.g. syndromic and non-syndromic XLID) duplication/deletion analysis panel of minimum 60 genes, including (ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes for multiple disorders involving methods as Multiplex Ligation dependent Probe Amplification (MLPA) | null | null | null |
733500571 | 73350-05-71 | Hearing loss panel | Hereditary retinal disorders (e.g. Usher syndrome, nonsyndromic hearing loss, Pendred syndrome); genome sequence analysis panel of at least 60 genes including (CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A, and WFS1). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | Analysis of at least 60 genes, panel must include listed genes |
733500572 | 73350-05-72 | Hearing loss; Dup/Del Panel | Hearing loss disorders (e.g. Usher syndrome, nonsyndromic hearing loss, Pendred syndrome);duplication and deletion analysis panel, including (STRC and DFNB1 copy number analysis; and GJB2 and GJB6 gene deletions). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes for multiple disorders involving methods as Multiplex Ligation dependent Probe Amplification (MLPA) | null | null | null |
733500573 | 73350-05-73 | Hereditary retinal disorders panel | Hereditary Retinal Disorders (e.g. Leber congenital amaurosis, cone-rod dystrophy. retinitis pigmentosa) genome sequence analysis panel of minimum 15 genes, including (ABCA4, CNGA1, CRB1, EYS, PDE6A, PDE6B, PRPF31, PRPH2, RDH12, RHO, RP1, RP2, RPE65, RPGR, and USH2A) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | Do not separately code each of the genes listed in this panel. |
733500591 | 73350-05-91 | Hereditary colon cancer panel | Hereditary Colon Cancer (e.g. Cowden syndrome, Lynch syndrome, PTEN hamartoma syndrome, familial adenomatosis polyposis) genome sequence analysis panelof minimum 10 genes, including (APC, BMPR1A, CDH1, MLH1, MSH2, MSH6, MUTYH, PTEN, SMAD4, and STK11). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | Do not separately code each of the genes listed in this panel. |
733500240 | 73350-02-40 | PCA3/KLK3 gene; Ratio | Nonprotein coding prostate cancer antigen 3 (PCA3) and prostate specific antigen kallikrein related peptidase (KLK3) evaluation of gene ratio | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Evaluation of gene ratio (e.g. prostate cancer monitoring) | null | null | null |
733500250 | 73350-02-50 | PDGFRA gene; Target sequence | Platelet–derived growth factor receptor, alpha polypeptide (PDGFRA) specific sequence analysis on exon 12 and 18 | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection on specific site (e.g. gastrointestinal stromal tumor) | null | null | null |
733500592 | 73350-05-92 | Hereditary colon cancer dup/del panel | Hereditary Colon Cancer (e.g. Cowden syndrome, Lynch syndrome, PTEN hamartoma syndrome, familial adenomatosis polyposis) duplication/deletion analysis panel of minimum 5 genes, including (MLH1, MSH2, EPCAM, SMAD4, and STK11). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes for multiple disorders involving methods as Multiplex Ligation dependent Probe Amplification (MLPA) | null | null | Do not separately code each of the genes listed in this panel. |
733500593 | 73350-05-93 | Hereditary neuroendocrine tumors panel | Hereditary Neuroendocrine Tumor disorders (e.g. parathyroid carcinoma, medullary thyroid carcinoma, malignant pheochromocytoma or paraganglioma) genome sequence analysis panel of minimum 6 genes, including (MAX, SDHB, SDHC, SDHD, TMEM127, and VHL). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | Do not separately code each of the genes listed in this panel. |
733500594 | 73350-05-94 | Hereditary neuroendocrine tumors; dup/del panel | Hereditary Neuroendocrine Tumor disorders (e.g. parathyroid carcinoma, medullary thyroid carcinoma, malignant pheochromocytoma or paraganglioma) duplication/deletion analysis panel, including (SDHB, SDHC, SDHD, and VHL). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes for multiple disorders | null | null | Do not separately code each of the genes listed in this panel. |
733500595 | 73350-05-95 | Hereditary peripheral neuropathies panel | Hereditary Peripheral Neuropathies (e.g. Spastic paraplegia, Charcot-Marie-Tooth) genome sequence analysis panel of minimum 5 genes, including (BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, SPTLC1). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | Do not separately code each of the genes listed in this panel. |
733500596 | 73350-05-96 | Hereditary cardiomyopathy panel | Hereditary Cardiomyopathy Panel (e.g. dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy) genome sequence analysis panel of minimum 5 genes, including (DSG2, MYBPC3, MYH7, PKP2, TTN). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | Do not assign this code with (Cardiac Ion Channelopathies Panel or Cardiac Ion Channelopathies; Dup/Del Panel) if they're performed on the same date of service. Do not separately code each of the genes listed in this panel. |
733500597 | 73350-05-97 | Mitochondrial nuclear panel | Mitochondrial genes encoded in the nucleus (e.g. neurologic or myopathic phenotypes) genome sequence analysis panel of minimum 100 genes, including (BCS1L, C10orf2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, and TYMP). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | Mitochondrial genes encoded in the nucleus (e.g. neurologic or myopathic phenotypes) genome sequence analysis panel of minimum 100 genes, including (BCS1L, C10orf2, COQ2, Co10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, and TYMP). | null | null |
733500598 | 73350-05-98 | Noonan spectrum disorders panel | Noonan spectrum disorders (e.g. Noonan syndrome, Costello syndrome, LEOPARD syndrome, cardio-facio-cutaneous syndrome, Noonan-like syndrome) genome sequence analysis panel of minimum 12 genes, including (BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, and SOS1). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | Noonan spectrum Disorders (e.g. Noonan syndrome, Costello syndrome, LEOPARD syndrome, cardio-facio-cutaneous syndrome, Noonan-like syndrome) genome sequence analysis panel of minimum 12 genes, including (BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, and SOS1). | null | Do not separately code each of the genes listed in this panel. |
733500581 | 73350-05-81 | Hematolymphoid neoplasms panel; 5-50 genes | Hematolymphoid neoplasm; targeted genome sequence analysis panel (DNA or RNA) of 5-50 genes (e.g. BRAF, CEBPA, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KRAS, KIT, MLL, NRAS, NPM1, NOTCH1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders (blood or lymph cancers) involving methods as Next Generation Sequencing | null | null | Do not separately code each of the genes listed in this panel. |
733500582 | 73350-05-82 | Hematolymphoid neoplasms panel; >50 genes | Hematolymphoid neoplasm; targeted genome sequence analysis panel (DNA or RNA) of 51 or more genes (e.g. ALK, BRAF, CDKN2A, CEBPA, DNMT3A, EGFR, ERBB2, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MLL, NPM1, NRAS, MET, NOTCH1, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders (blood or lymph cancers) involving methods as Next Generation Sequencing | Hematolymphoid neoplasm; targeted genome sequence analysis panel (DNA or RNA) of 51 or more genes (e.g. ALK, BRAF, CDKN2A, CEBPA, DNMT3A, EGFR, ERBB2, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MLL, NPM1, NRAS, MET, NOTCH1, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET) | null | Do not separately code each of the genes listed in this panel. |
733500583 | 73350-05-83 | Mitochondrial genome | Whole mitochondrial genome (e.g. mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], Leigh syndrome, neuropathy, ataxia, and retinitis pigmentosa [NARP], myoclonic epilepsy with ragged-red fibers [MERFF], Leber hereditary optic neuropathy [LHON]); sequence analysis with heteroplasmy detection. | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of the entire mitochondrial genome (nerve or muscle pathologies) | Whole mitochondrial genome (e.g. mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], Leigh syndrome, neuropathy, ataia, and retinitis pigmentosa [NARP], myoclonic epilepsy with ragged-red fibers [MERFF], Leber hereditary optic neuropathy [LHon]); sequence analysis with heteroplasmy detection. | null | null |
733500584 | 73350-05-84 | Mitochondrial genome; large deletions | Whole mitochondrial genome (e.g. mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], Leigh syndrome, neuropathy, ataxia, and retinitis pigmentosa [NARP], myoclonic epilepsy with ragged-red fibers [MERFF], Leber hereditary optic neuropathy [LHON]); large deletions analysis with heteroplasmy detection (when conducted). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of the entire mitochondrial genome for large deletions (nerve or muscle pathologies) | Whole mitochondrial genome (e.g. mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], Leigh syndrome, neuropathy, ataia, and retinitis pigmentosa [NARP], myoclonic epilepsy with ragged-red fibers [MERFF], Leber hereditary optic neuropathy [LHon]); large deletions analysis with heteroplasmy detection (when conducted). | null | null |
733500611 | 73350-06-11 | Heart transplant rejection risk | Measurement of potential heart transplant patient risk score by mRNA gene expression profiling of 20 genes utilizing quantitative polymerase chain reaction (QPCR) and peripheral blood subfraction | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for heart transplant | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500612 | 73350-06-12 | CAD risk | Measurement of coronary artery disease (CAD) risk score by mRNA gene expression profiling of 23 genes utilizing real time polymerase chain reaction (RT-PCR) from whole peripheral blood | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for CAD | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500613 | 73350-06-13 | T2DM risk | Measurement of type 2 diabetes (T2DM) risk score for 7 analytes by biochemical assays from serum or plasma | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for T2DM | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500640 | 73350-06-40 | Tumor tissue origin profiling | Measurement of tumor tissue (unknown origin) similarity score to existing tumor database utilizing microarray gene expression profiling of > 2000 genes from formalin-fixed paraffin-embedded tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for RNA expression patterns in a tumor of unknown origin and comparison to tumor database. | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500641 | 73350-06-41 | Tumor tissue classification | Analysis of tumor tissue (unknown origin) for classification of main cancer type and subtype by gene expression profiling of 92 genes (87 content; 5 housekeeping) utilizing real time reverse transcription polymerase chain reaction (RT–PCR) from formalin-fixed paraffin-embedded tumor tissue. | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for tumor tissue classification | Analysis of tumor tissue (unknown origin) for classification of main cancer type and subtype by gene epression profiling of 92 genes (87 content; 5 housekeeping) utilizing real time reverse transcription polymerase chain reaction (RT–PCR) from formalin-fied paraffin-embedded tumor tissue. | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500642 | 73350-06-42 | Uveal melanoma risk | Measurement of uveal melanoma metastatic risk score by mRNA gene expression profiling of 15genes (12 content; 3 housekeeping) utilizing real time reverse transcription polymerase chain reaction (RT–PCR) from fine needle aspirate or formalin-fixed paraffin-embedded tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for uveal melanoma risk | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500643 | 73350-06-43 | Usual interstitial pneumonia screen | Screening for Usual Interstitial Pneumonia (UIP) (positive/negative) by mRNA gene expression profiling of 190 genes from transbronchial biopsies | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for UPI risk | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500644 | 73350-06-44 | Pediatric liver/small bowel allograft rejection risk | Measurement of pediatric Liver or Small Bowel allograft-transplant rejection risk-score for (CD154+T-cytotoxic memory cells) from whole peripheral blood | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for pediatric liver allograft rejection risk | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500701 | 73350-07-01 | Bacterial vaginosis screen | Detection of bacterial vaginosis RNA markers of (Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species) by quantitative real-time amplification from vaginal-fluid | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for BV | Detection of bacterial vaginosis & vaginitis DNA markers of (Gardnerella vaginalis, atopobium vaginae, Lactobacillus species (L. crispatus & L. jensenii), Megasphaera type 1, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)) with detection of Trichomonas vaginalis and Candida species by quantitative real-time amplification from vaginal-fluid | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |